Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Medicines · US (FDA)

FDA 1981

Ethers, chemically close to antihistamines

Orphenadrine Citrate

Approved 16 Jul 1981InjectionInjectable

The FDA lists this product in 13 strengths and forms.

Official labelAsk Osler about it

On this page

Composition
Strengths and forms
Official product information

The table holds no label text for this product yet, only the facts beside it. The official product information has the full text.

Composition

Active ingredients: ORPHENADRINE CITRATE 30MG/ML

Strengths and forms

The FDA lists each strength of a product separately; these pages share one label.

ORPHENADRINE CITRATE 100MG · Tablet, extended releaseANDA091158-001 · Prescription
ORPHENADRINE CITRATE 30MG/ML · InjectableANDA084779-001 · Prescription
ORPHENADRINE CITRATE 30MG/ML · InjectableThis page
ORPHENADRINE CITRATE 100MG · Tablet, extended releaseANDA085046-001 · Discontinued
ORPHENADRINE CITRATE 100MG · Tablet, extended releaseANDA040327-001 · Prescription
ORPHENADRINE CITRATE 30MG/ML · InjectableANDA040463-001 · Prescription
ORPHENADRINE CITRATE 100MG · Tablet, extended releaseANDA088067-001 · Discontinued
ORPHENADRINE CITRATE 100MG · Tablet, extended releaseANDA040249-001 · Prescription
ORPHENADRINE CITRATE 100MG · Tablet, extended releaseANDA040284-001 · Prescription
ORPHENADRINE CITRATE 100MG · Tablet, extended release

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

ANDA084303-001 · Discontinued

ORPHENADRINE CITRATE 100MG · Tablet, extended releaseANDA040368-001 · Discontinued

ORPHENADRINE CITRATE 30MG/ML · InjectableANDA040484-001 · Prescription

ORPHENADRINE CITRATE 30MG/ML · InjectableANDA090585-001 · Prescription

Official product information

Drugs@FDA lists the approved labels, letters and reviews for application ANDA087062.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Brand name: Orphenadrine Citrate
Drug class: Ethers, chemically close to antihistamines
Route: Injection
Dosage form: Injectable
Applicant: Watson Labs
Status: Discontinued
FDA approval: 16 Jul 1981
Application: ANDA087062-001
RxCUI: 7716